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Haemostasis is a physiological process that stops blood loss at the 
site of injury, while maintaining normal blood flow in the rest of the 
circulation. 
This is accomplished in three physiological steps that occur in 
rapid sequence: (i) vasoconstriction; (ii) formation of a platelet plug 
(primary haemostasis); and (iii) stabilisation of clot through cross-
link ing of insoluble fibrin (secondary haemostasis). 
The fibrin mesh that is incorporated into and around the platelet 
plug serves to strengthen and stabilise the blood clot. Apart from 
limiting blood loss, the clot allows for vessel and tissue repair. 
Anticoagulant mechanisms regulate the coagulation system to ensure 
formation of a clot that is proportional to the injury. A delicate 
balance between procoagulant and anticoagulant systems is critical 
for proper haemostasis and for avoiding pathological bleeding or 
thrombosis. The clot is finally dissolved by the fibrinolytic system, 
which also performs the function of preventing blood clots in healthy 
blood vessels. 
Bleeding disorders are divided into two broad categories: (i) inhe-
rited (discussed in part 1);[1] and (ii) acquired (part 2, current 
issue).[2] This is the second of a two-part CME series on bleeding 
disorders. 
Bleeding manifestations from acquired causes are generally less 
severe than in the inherited forms and the clinical picture is often 
dominated by features of the underlying disorder. In clinical practice, 
however, bleeding is frequently a presenting manifestation of syste-
mic disease and necessitates a multidisciplinary team approach. 
Investigation of abnormal bleeding requires a comprehensive history, 
thorough physical examination and systematic laboratory work-up. 
For the laboratory work-up, an algorithmic approach is incorporated 
in the article in the current issue as Fig. 1.[2] Basic laboratory tests, 
viz. international normalised ratio, partial thromboplastin time, full 
blood count and blood smear microscopy, characterise the nature 
and extent of the coagulation defect/s and provide a basis for further 
investigations. It is important to understand the mechanism of 
haemostatic disturbances that may be applicable to specific disease 
processes, as interpretation of laboratory findings depends to a large 
extent on clinical circumstances.
This CME aims to provide an approach to diagnosis and management 
of acquired bleeding disorders encountered in general practice. 
Elaborate discussion on the wide variety of bleeding disorders 
is not possible, but more common conditions such as immune 
thrombocytopenia are discussed in greater detail. Complex 
haemostatic derangements may occur in specific clinical scenarios 
with varying degrees of bleeding and thrombosis. These include 
cardiopulmonary bypass, trauma, massive blood loss, liver 
transplantation and complications of pregnancy. Such scenarios 
are influenced by a multitude of factors with varied aetiologies that 
merit discussion on discipline-specific platforms, and are therefore 
beyond the scope of this CME. Select therapeutic modalities may fall 
outside the scope of general practice, but are nonetheless included to 
familiarise readers with available therapies.
The authors are indeed grateful for the opportunity to discuss 
the subject of bleeding disorders, 
which is an important and dynamic 
sphere of coagulation.
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